Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms

J. Kralova, M. Kolar, M. Kahle, J. Truksa, S. Lettlova, K. Balusikova, P. Bartunek,

. 2017 ; 7 (-) : 44497. [pub] 20170315

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19001296

The development of drug resistance is a major problem which often occurs during anticancer chemotherapies. Photodynamic therapy (PDT) has been studied as an alternative treatment modality for drug-resistant tumors, however the question of resistance to PDT and potential cross-resistance with chemotherapy has yet to be fully answered. To investigate the mechanism of resistance to PDT, we developed an in vitro experimental model system in a mouse mammary carcinoma cell line 4T1. We used two ethylene glycol derivatives of tetraphenylporphyrin, and tetraphenylchlorin derivative, temoporfin, as photosensitizers (PS). PDT-resistant clones were obtained by exposure to a set concentration of PS followed by irradiation with increasing light doses. PDT resistance to soluble glycol porphyrins was mediated mainly by increased drug efflux through ABCB1 (P-glycoprotein) as we demonstrated by specific ABCB1 knockdown experiments, which in turn rescued the sensitivity of resistant cells to PDT. In contrast, resistance raised to temoporfin, which is generally more lipophilic than glycol porphyrins, elicited mechanism based on sequestration of the drug to lysosomes. The resistance that is acquired from a particular PS could be overcome by using a different PS, which is not susceptible to the same mechanism(s) of resistance. Elucidation of the underlying mechanisms in various types of resistance might facilitate improvements in PDT treatment design.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19001296
003      
CZ-PrNML
005      
20200121142058.0
007      
ta
008      
190107s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/srep44497 $2 doi
035    __
$a (PubMed)28295025
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kralova, Jarmila $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic.
245    10
$a Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms / $c J. Kralova, M. Kolar, M. Kahle, J. Truksa, S. Lettlova, K. Balusikova, P. Bartunek,
520    9_
$a The development of drug resistance is a major problem which often occurs during anticancer chemotherapies. Photodynamic therapy (PDT) has been studied as an alternative treatment modality for drug-resistant tumors, however the question of resistance to PDT and potential cross-resistance with chemotherapy has yet to be fully answered. To investigate the mechanism of resistance to PDT, we developed an in vitro experimental model system in a mouse mammary carcinoma cell line 4T1. We used two ethylene glycol derivatives of tetraphenylporphyrin, and tetraphenylchlorin derivative, temoporfin, as photosensitizers (PS). PDT-resistant clones were obtained by exposure to a set concentration of PS followed by irradiation with increasing light doses. PDT resistance to soluble glycol porphyrins was mediated mainly by increased drug efflux through ABCB1 (P-glycoprotein) as we demonstrated by specific ABCB1 knockdown experiments, which in turn rescued the sensitivity of resistant cells to PDT. In contrast, resistance raised to temoporfin, which is generally more lipophilic than glycol porphyrins, elicited mechanism based on sequestration of the drug to lysosomes. The resistance that is acquired from a particular PS could be overcome by using a different PS, which is not susceptible to the same mechanism(s) of resistance. Elucidation of the underlying mechanisms in various types of resistance might facilitate improvements in PDT treatment design.
650    _2
$a ABC transportér, podrodina B, člen 11 $x genetika $7 D000074020
650    _2
$a zvířata $7 D000818
650    _2
$a chemorezistence $x genetika $7 D019008
650    _2
$a ethylenglykoly $x aplikace a dávkování $x chemie $7 D005026
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genový knockdown $7 D055785
650    _2
$a glykoly $x chemie $7 D006018
650    _2
$a lidé $7 D006801
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a nádory mléčné žlázy u zvířat $x farmakoterapie $x genetika $x patologie $7 D015674
650    _2
$a mesoporfyriny $x aplikace a dávkování $x chemie $7 D008652
650    _2
$a myši $7 D051379
650    _2
$a paclitaxel $x škodlivé účinky $7 D017239
650    _2
$a fotochemoterapie $7 D010778
650    _2
$a fotosenzibilizující látky $x aplikace a dávkování $x chemie $7 D017319
650    _2
$a porfyriny $x aplikace a dávkování $x chemie $7 D011166
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kolar, Michal $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic. Laboratory of Genomics and Bioinformatics, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic.
700    1_
$a Kahle, Michal $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic.
700    1_
$a Truksa, Jaroslav $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic. Laboratory of Tumor Resistance, Institute of Biotechnology of the ASCR, v. v. i., BIOCEV, Vestec, Prague-West, Czech Republic.
700    1_
$a Lettlova, Sandra $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic. Laboratory of Tumor Resistance, Institute of Biotechnology of the ASCR, v. v. i., BIOCEV, Vestec, Prague-West, Czech Republic.
700    1_
$a Balusikova, Kamila $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic. Division of Cell and Molecular Biology &Center for Research of Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University in Prague, Czech Republic.
700    1_
$a Bartunek, Petr $u CZ-OPENSCREEN: National Infrastructure for Chemical Biology, Institute of Molecular Genetics of the ASCR, v. v. i., Prague, Czech Republic.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 44497
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28295025 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190107 $b ABA008
991    __
$a 20200121142435 $b ABA008
999    __
$a ok $b bmc $g 1365181 $s 1039419
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 7 $c - $d 44497 $e 20170315 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20190107

Najít záznam

Citační ukazatele

Možnosti archivace